Publications by authors named "Mark Baugh"

Claim this Profile
L
LIM kinase inhibitors disrupt mitotic microtubule organization and impair tumor cell proliferation.
Katerina Mardilovich, Mark Baugh, Diane Crighton, Dominika Kowalczyk, Mads Gabrielsen

Oncotarget· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cucurbitacin covalent bonding to cysteine thiols: the filamentous-actin severing protein Cofilin1 as an exemplary target.
Mads Gabrielsen, Maike Schuldt, June Munro, Dagmara Borucka, Jenifer Cameron, Mark Baugh

Cell Commun Signal· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Rho GTPase signaling for cancer therapy.
Katerina Mardilovich, Michael F Olson, Mark Baugh

Future Oncol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic dosing of an orally active, selective cathepsin S inhibitor suppresses disease in models of autoimmunity.
Mark Baugh, Darcey Black, Paul Westwood, Emma Kinghorn, Kieran McGregor

J Autoimmun· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
1H-imidazo[4,5-c]pyridine-4-carbonitrile as cathepsin S inhibitors: separation of desired cellular activity from undesired tissue accumulation through optimization of basic nitrogen pka.
Wullie Arbuckle, Mark Baugh, Simone Belshaw, D Jonathan Bennett, John Bruin

Bioorg Med Chem Lett· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trifluoromethylphenyl as P2 for ketoamide-based cathepsin S inhibitors.
Jiaqiang Cai, John Robinson, Simone Belshaw, Kathryn Everett, Xavier Fradera, Mark Baugh

Bioorg Med Chem Lett· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimisation of 2-cyano-pyrimidine inhibitors of cathepsin K: improving selectivity over hERG.
Zoran Rankovic, Jiaqiang Cai, Jennifer Kerr, Xavier Fradera, John Robinson, Mark Baugh

Bioorg Med Chem Lett· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
4-(3-Trifluoromethylphenyl)-pyrimidine-2-carbonitrile as cathepsin S inhibitors: N3, not N1 is critically important.
Jiaqiang Cai, Xavier Fradera, Mario van Zeeland, Maureen Dempster, Kenneth S Cameron, Mark Baugh

Bioorg Med Chem Lett· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-Phenyl-9H-purine-6-carbonitrile derivatives as selective cathepsin S inhibitors.
Jiaqiang Cai, D Jonathan Bennett, Zoran Rankovic, Maureen Dempster, Xavier Fradera, Mark Baugh

Bioorg Med Chem Lett· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
6
6-Phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile as cathepsin S inhibitors.
Jiaqiang Cai, Mark Baugh, Darcey Black, Clive Long, D Jonathan Bennett

Bioorg Med Chem Lett· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and optimization of a series of novel 2-cyano-pyrimidines as cathepsin K inhibitors.
Zoran Rankovic, Jiaqiang Cai, Jennifer Kerr, Xavier Fradera, John Robinson, Mark Baugh

Bioorg Med Chem Lett· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monocyte matrix and ADAM metalloproteinase expression in type 2 diabetes after aspirin therapy.
Mike Sampson, Steven Wall, Mark Baugh, Jo Worley, Isabel Davies

Diabetes Res Clin Pract· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metalloproteinase expression in PMA-stimulated THP-1 cells. Effects of peroxisome proliferator-activated receptor-gamma (PPAR gamma) agonists and 9-cis-retinoic acid.
Joanna R Worley, Mark D Baugh, David A Hughes, Dylan R Edwards, Aileen Hogan

J Biol Chem· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monocyte matrix metalloproteinase production in Type 2 diabetes and controls--a cross sectional study.
Mark D Baugh, Jelena Gavrilovic, Isabel R Davies, David A Hughes, Mike J Sampson

Cardiovasc Diabetol· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis